Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma
3 意见
• 07/18/23
0
0
嵌入
Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the effectiveness of monoclonal antibody olaratumab in combination with doxorubicin in unresectable and metastatic soft tissue sarcoma.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论